Crispr is the exception:

1. it’s massively expensive
2. it can cure multiple illnesses and perform loads of other functions

Most proposals for cures are a fairly simple (and cheap) therapeutic target that will only work for one condition or even just a subset of cases within that condition.

That’s the lenient interpretation I’d hope.

But we’re not an alternative medicine group or anything. If you look into their shareholder meetings the public info seems to be that they judge whether investments are worth it by potential return on investment, and well a lifelong treatment is always going to be more profitable for them than a cure.

Completely true. But there would be fewer of them.

It’s crazy that when my research team comes up with a therapeutic target we believe might lead to curing a disease, we get crickets from drug companies. But when we present therapeutic targets for long term treatment, we get lots of interest.

FYI, you seem to be new here and seem not to be far-left. For your future enjoyment of lemmy, note that Lemmy.ML is a communist instance and therefore you may not like some of the content there.